DOWN-REGULATION OF MIR-203-B IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS

被引：0
|
作者：
Ryabchikova, N. [1 ]
Safuanova, G. [1 ]
Minniakhmetov, I. [2 ]
Karunas, A. [2 ]
Yalaev, B. [2 ]
Shut, E. [2 ]
Latypov, R. [2 ]
Khusnutdinova, E. [2 ]
机构：
[1] Bashkir State Med Univ, Ufa, Russia
[2] UFA, IBG USC RAS, Ufa, Russia
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1733
引用
收藏
页码：686 / 686
页数：1
相关论文
共 50 条
  • [1] Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
    Neda Mosakhani
    Satu Mustjoki
    Sakari Knuutila
    Molecular Cytogenetics, 6
  • [2] Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
    Mosakhani, Neda
    Mustjoki, Satu
    Knuutila, Sakari
    MOLECULAR CYTOGENETICS, 2013, 6
  • [3] Management of imatinib-resistant patients with chronic myeloid leukemia
    Bhamidipati, Pavan Kumar
    Kantarjian, Hagop
    Cortes, Jorge
    Cornelison, A. Megan
    Jabbour, Elias
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (02) : 103 - 117
  • [4] DASATINIB TREATMENT OF IMATINIB-RESISTANT AND IMATINIB-INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN A CHRONIC PHASE
    Vinogradova, O. Yu.
    Turkina, A. G.
    Vorontsova, A. V.
    Chelysheva, E. Yu.
    Gusarova, G. A.
    Kuznetsov, S. V.
    Goryacheva, S. R.
    Sokolova, M. A.
    Abakumov, E. M.
    Stakhina, O. V.
    Domracheva, E. V.
    Misyurin, A. V.
    Khoroshko, N. D.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (07) : 41 - 46
  • [5] Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
    Frank, O.
    Brors, B.
    Fabarius, A.
    Li, L.
    Haak, M.
    Merk, S.
    Schwindel, U.
    Zheng, C.
    LEUKEMIA, 2006, 20 (08) : 1400 - 1407
  • [6] An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia
    Agarwal, A.
    Eide, C. A.
    Harlow, A.
    Corbin, A. S.
    Mauro, M. J.
    Druker, B. J.
    Corless, C. L.
    Heinrich, M. C.
    Deininger, M. W.
    LEUKEMIA, 2008, 22 (12) : 2269 - 2272
  • [7] An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia
    A Agarwal
    C A Eide
    A Harlow
    A S Corbin
    M J Mauro
    B J Druker
    C L Corless
    M C Heinrich
    M W Deininger
    Leukemia, 2008, 22 : 2269 - 2272
  • [8] Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
    O Frank
    B Brors
    A Fabarius
    L Li
    M Haak
    S Merk
    U Schwindel
    C Zheng
    M C Müller
    N Gretz
    R Hehlmann
    A Hochhaus
    W Seifarth
    Leukemia, 2006, 20 : 1400 - 1407
  • [9] Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation
    Qi Shen
    Sichu Liu
    Yu Chen
    Lijian Yang
    Shaohua Chen
    Xiuli Wu
    Bo Li
    Yuhong Lu
    Kanger Zhu
    Yangqiu Li
    Journal of Hematology & Oncology, 6
  • [10] Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation
    Shen, Qi
    Liu, Sichu
    Chen, Yu
    Yang, Lijian
    Chen, Shaohua
    Wu, Xiuli
    Li, Bo
    Lu, Yuhong
    Zhu, Kanger
    Li, Yangqiu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
12345